what is happening at the bleeding edge, leaves the "ingenuity factor" of vaccine tech in the dust.
Engineered cell signaling and constitutive proteomics.
Some of the stuff at the bleeding edge though like gene therapy is so expensive at millions of dollars per patient that health insurance companies
are not covering it, so that stuff is not actually worthwhile to that many patients. The vaccine tech is covered by health insurance.